|
CASC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.24050042144597E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.0701001436978E-10 |
| Normal-vs-Stage2 |
2.220600E-03 |
| Normal-vs-Stage3 |
8.19170000000424E-05 |
| Normal-vs-Stage4 |
6.126100E-02 |
| Stage1-vs-Stage2 |
6.413800E-01 |
| Stage1-vs-Stage3 |
8.802200E-01 |
| Stage1-vs-Stage4 |
9.219600E-01 |
| Stage2-vs-Stage3 |
6.318800E-01 |
| Stage2-vs-Stage4 |
7.265200E-01 |
| Stage3-vs-Stage4 |
9.715400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83990001012546E-09 |
| Normal-vs-AfricanAmerican |
2.17500000232462E-08 |
| Normal-vs-Asian |
1.622840E-01 |
| Caucasian-vs-AfricanAmerican |
7.931000E-01 |
| Caucasian-vs-Asian |
8.318200E-01 |
| AfricanAmerican-vs-Asian |
7.227600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.11689554774352E-11 |
| Normal-vs-Female |
2.023100E-03 |
| Male-vs-Female |
4.341100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.595030E-04 |
| Normal-vs-Extreme_Weight |
4.82770490251028E-11 |
| Normal-vs-Obese |
1.49739999955045E-07 |
| Normal-vs-Extreme_Obese |
1.57808999999842E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.305600E-01 |
| Normal_Weight-vs-Obese |
8.784400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.255800E-01 |
| Extreme_Weight-vs-Obese |
1.120240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.052600E-01 |
| Obese-vs-Extreme_Obese |
4.514600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.958000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.08049999999016E-05 |
| Normal-vs-Age(61-80Yrs) |
2.95452551313247E-12 |
| Normal-vs-Age(81-100Yrs) |
6.74699962566194E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.812190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.003170E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.79450000000037E-05 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.457760E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.636750E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.217500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.41469999551214E-09 |
| Normal-VS-Type2 PRCC |
5.50620005146385E-09 |
| Normal-VS-KIRP CIMP |
5.417200E-03 |
| Normal-VS-Unclassified PRCC |
3.151800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.997420E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.836200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.551780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.117600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.446100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.723830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6615997466829E-10 |
| Normal-vs-N1 |
3.100200E-02 |
| Normal-vs-N2 |
1.092230E-02 |
| N0-vs-N1 |
2.152000E-01 |
| N0-vs-N2 |
6.286400E-01 |
| N1-vs-N2 |
8.050000E-01 |
|
|
